Naomi Walsh

7PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 20, 2025
Chromosome centromere copy number amplification associated with exceptional response in HER2-positive metastatic breast cancer patients.

Charlotte Andrieu, Jojanneke Stoof, Dalal AlSultan

|Mar 17, 2025
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity.

Mirco Masi, Laura Poppi, Viola Previtali

|Aug 29, 2024
Molecular Analysis of Salivary and Lacrimal Adenoid Cystic Carcinoma.

Sarah Powell, Karina Kulakova, Katie Hanratty

|Jun 23, 2022
Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes.

Charlotte Andrieu, Niamh McNamee, Anne-Marie Larkin

|Jan 11, 2021
Genomic Profiling and Functional Analysis of let-7c miRNA-mRNA Interactions Identify <i>SOX13</i> to Be Involved in Invasion and Progression of Pancreatic Cancer.

Shannon R Nelson, Sandra Roche, Maura Cotter

|Jul 28, 2020
Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer.

Naomi Walsh, Charlotte Andrieu, Peter O'Donovan

Pageof 2

Frequent Collaborators

2 joint publications

Kai Yu

1 joint publications

Fangcheng Yuan

1 joint publications

Rayjean J Hung

1 joint publications

Elizabeth A Platz